{"organizations": [], "uuid": "f1dd823d501c92b4126a70a660f06fbc705160e8", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180221.html", "section_title": "Archive News &amp; Video for Wednesday, 21 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-mizuho-medy-obtains-marketing-and/brief-mizuho-medy-obtains-marketing-and-manufacture-approval-of-mycoplasma-nucleic-acid-kit-for-genetic-poct-examination-idUSL4N1QC0V5", "country": "US", "domain_rank": 408, "title": "BRIEF-Mizuho Medy obtains marketing and manufacture approval of mycoplasma nucleic acid kit for genetic POCT examination", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.086, "site_type": "news", "published": "2018-02-22T10:46:00.000+02:00", "replies_count": 0, "uuid": "f1dd823d501c92b4126a70a660f06fbc705160e8"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-mizuho-medy-obtains-marketing-and/brief-mizuho-medy-obtains-marketing-and-manufacture-approval-of-mycoplasma-nucleic-acid-kit-for-genetic-poct-examination-idUSL4N1QC0V5", "ord_in_thread": 0, "title": "BRIEF-Mizuho Medy obtains marketing and manufacture approval of mycoplasma nucleic acid kit for genetic POCT examination", "locations": [], "entities": {"persons": [{"name": "brief-mizuho medy", "sentiment": "negative"}], "locations": [{"name": "japan", "sentiment": "none"}], "organizations": [{"name": "mizuho medy co ltd", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "beijing headline news", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 22 (Reuters) - Mizuho Medy Co Ltd\n* Says it obtained the marketing and manufacture approval of mycoplasma nucleic acid kit for genetic POCT examination in Japan on Feb. 19\nSource text in Japanese: goo.gl/LVabQk\nFurther company coverage: (Beijing Headline News)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html", "https://goo.gl/LVabQk"], "published": "2018-02-22T10:46:00.000+02:00", "crawled": "2018-02-22T18:05:47.003+02:00", "highlightTitle": ""}